Oncolytic Virus Therapies Market Study Report Based on Company Profile , Key Vendor , Future Growth And Outlook 2028

oncolytic virus therapies market size is expected to reach USD 609.7 Million at a steady CAGR of 26.2% in 2028, according to latest analysis by Emergen Research. Rise in prevalence of cancer, increase in number of clinical trials and investment in research & development for cancer therapies are driving the growth of oncolytic virus therapies market.

Oncolytic virus is a virus which infects and kills cancer cells and as these cancer cells are destroyed by oncolysis, they release new infectious particles which destroy remaining tumor. Cancer mortality rate is 158.3 per 100,000 people per year. Estimated national expense for cancer in the U.S. was USD 150.8 billion in 2018. This cost is likely to increase as population ages and need for development of new effective therapies will fuel oncolytic virus therapies market growth.

The report offers a comprehensive overview of the market along with details about market size, market share, revenue growth, and top companies. The report covers all crucial and essential information related to global Oncolytic Virus Therapies market to help readers, investors, clients to gain a thorough understanding of the market and invest accordingly. Various advanced statistical tools such as SWOT analysis or Porter’s Five Forces are used in the report.

We Have Recent Updates of Oncolytic Virus Therapies Market in Sample Copy: https://www.emergenresearch.com/request-sample/704

The primary aim of the report is to offer market overview, product scope, growth prospects, and risks. The report also offers in depth information about each player in the global Oncolytic Virus Therapies market along with its global standing, financial status, product launch, business expansion plans among others. The market players are focused on developing various strategies such as partnerships, mergers and acquisitions, joint ventures, product launches, and research and development investments.

Companies profiled in the global Oncolytic Virus Therapies market:

Oncolytics Biotech, Inc., Amgen Inc., Sorrento Therapeutics, Inc., Transgene SA, Daiichi Sankyo Company, Limited, Shanghai Sunway Biotech Co., Ltd., Takara Bio Inc., PsiOxus Therapeutics, SillaJen, Inc., and ViroCure.

The report also covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region.

Oncolytic Virus Therapies Market segmentation

Emergen Research has segmented the global oncolytic virus therapies market on the basis of virus type, application, end-use, and region:

  • Virus Type Outlook (Revenue, USD Million; 2018–2028)
    • Genetically Engineered Oncolytic Viruses
      1. Herpes Simplex Virus
      2. Adenovirus
      3. Vaccinia Virus
    • Oncolytic Wild-Type Viruses
      1. Reovirus
      2. Newcastle Disease Virus
      3. Vesicular Stomatitis Virus
  • Application Outlook (Revenue, USD Million; 2018–2028)
    • Solid Tumors
      1. Breast Cancer
      2. Prostate Cancer
      3. Lung Cancer
      4. Glioblastoma
    • Melanoma
      1. Hematological Malignancies
      2. Lymphoma
      3. Leukemia
      4. Myeloma
  • End-use Outlook (Revenue, USD Million; 2018–2028)
    • Hospitals
    • Specialty Clinics
    • Cancer Research Institute

Regional segmentation comprises of a current and forecast estimation of the market in the key geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Regional Outlook of Oncolytic Virus Therapies Market:

  • North America
    • S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • A.E.
    • South Africa
    • Rest of MEA

Key Features of the Oncolytic Virus Therapies Market Report:

  • The report offers details about key drivers, restraints, opportunities, challenges, growth prospects, limitations, and threats
  • The report encompasses details about the key companies, product portfolio along with specifications, production valuation, and market shares
  • Evaluation of key current and emerging market trends and growth prospects
  • It also offers research-backed estimations for the forecast period of eight years, primarily to estimate the potential market growth
  • Brief overview of industry with regards to research and development, technological advancements, and product development
  • In-depth assessment of upstream raw materials, downstream buyers, demands, and current market scenario

Request a customization of the report @ https://www.emergenresearch.com/request-for-customization/704

Browse More Healthcare and Pharmaceuticals Reports:

 Bioanalytical Testing Services Market Research Report – Forecast 2028

 2D Chromatography Market Research Report- Forecast 2028

 Laboratory Centrifuges Market Research Report- Global Forecast To 2028

 Orthopedic Biomaterial Market Research Report-Global Forecast Till 2028

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkdIn | Twitter | Blogs

You may also like...

Leave a Reply

Your email address will not be published.